Markers of platelet activation and platelet-leukocyte interaction in patients with myeloproliferative syndromes

Thrombosis Research

Volumn 108, Issue 2-3, 2002, Pages 139-145

  Villmow, Torben ^a   Kemkes Matthes, Bettina ^a   Matzdorff, Axel C ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Flow cytometry; Myeloproliferative syndromes; Platelet activation; Platelet leukocyte conjugates

Indexed keywords

BIOLOGICAL MARKER; CD14 ANTIGEN; CD45 ANTIGEN; PADGEM PROTEIN;

ADULT; AGED; ARTICLE; BLOOD; CATALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; LEUKOCYTE; MALE; MYELOFIBROSIS; MYELOID LEUKEMIA; MYELOPROLIFERATIVE DISORDER; POLYCYTHEMIA; PRIORITY JOURNAL; THROMBIN TIME; THROMBOCYTE ACTIVATION; THROMBOSIS; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 0036878184     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(02)00354-7     Document Type: Article

References (37)

1. Schafer A.I. Bleeding and thrombosis in the myeloproliferative disorders. Blood. 64:1984;1-12.
2. Wehmeier A., Schneider W. Megakaryocytes and platelets as the main cause for vascular events in chronic myeloproliferative disorders. Hämostaseologie. 16:1996;151-163.
3. Michielis J.J. Aspirin and platelet-lowering agents for the prevention of vascular complications in essential thrombocythemia. Clin. Appl. Thromb. Hemost. 5:1999;247-251.
4. Wehmeier A., Tschöpe D., Esser J., Menzel C., Nieuwenhuis H.K., Schneider W. Circulating activated platelets in myeloproliferative disorders. Thromb. Res. 61:1991;271-278.
5. Cahill M.R., Macey M.G., Newland A.C. Correlation of GP53 and p-selectin expression in myeloproliferative disorders and normal controls. Blood Coagul. Fibrinolysis. 7:1996;169-171.
6. Griesshammer M., Beneke H., Nussbauerm B., Grünewald M., Bangerter M., Bergmann L. Increased platelet surface expression of p-selectin and thrombospondin as markers of platelet activation in essential thrombocythaemia. Thromb. Res. 96:1999;191-196.
7. De Gaetano G., Cerletti C., Evangelista V. Recent advances in platelet-polymorphonuclear leukocyte interaction. Haemostasis. 29:1999;41-49.
8. Neumann F.J., Zohlnhöfer D., Fakhoury L., Ott I., Gawaz M., Schömig A. Effect of glycoprotein IIb/IIIa receptor blockade on platelet-leukocyte interaction and surface expression of the leukocyte integrin Mac-1 in acute myocardial infarction. J. Am. Coll. Cardiol. 34:1999;1420-1426.
9. Khairy M., Lasne D., Brohard-Bohn B., Aiach M., Rendu F., Bachelot-Loza C. A new approach in the study of the molecular and cellular events implicated in heparin-induced thrombocytopenia. Formation of leukocyte-platelet aggregates. Thromb. Haemost. 85:2001;1090-1096.
10. Yeo E.L., Sheppard J.A.I., Feuerstein I.A. Role of p-selectin and leukocyte activation in polymorphonuclear cell adhesion to surface adherent activated platelets under physiologic shear conditions (an injury vessel wall model). Blood. 83:1994;2498-2507.
11. Fisher T.C., Meiselmann H.J. Polymorphonuclear leukocytes in ischemic vascular disease. Thromb. Res. 74(Suppl. I):1994;S21-S34.
12. Falanga A., Marchetti M., Evangelista V., Vignoli A., Licini M., Balicco M.et al. Polymorphonuclear leukocyte activation and hemostasis in patients with essential thrombocythemia and polycythemia vera. Blood. 96:2000;4261-4266.
13. Redlich H., Vickers J., Lösche W., Heptinstall S., Kehrel B., Spangenberg P. Formation of platelet-leukocyte conjugates in whole blood. Platelets. 8:1997;419-425.
14. Brodmann S., Passweg J.R., Gratwohl A., Tichelli A., Skoda R.C. Myeloproliferative disorders: complications, survival and causes of death. Ann. Hematol. 79:2000;312-318.
15. Landolfi R., Marchioli R., Patrono C. Mechanisms of bleeding and thrombosis in myeloproliferative disorders. Thromb. Haemost. 78:1997;617-621.
16. Barbui T., Cortelazzo S., Viero P., Bassan R., Dini E., Semeraros N. Thrombohaemorrhagic complications in 101 cases of myeloproliferative disorders: relationship to platelet number and function. Eur. J. Cancer Clin. Oncol. 19:1983;1593-1599.
17. Kitchens C.S. Concept of hypercoagulability. Semin. Thromb. Hemost. 11:1985;293-315.
18. Kaplan R., Baggeta J., Sun L., Mao G.F., Rao A.K. Combined defect in membrane expression and activation of platelet GPIIb-IIIa complex without primary sequence abnormalities in myeloproliferative disease. Br. J. Haematol. 111:2000;954-964.
19. Matzdorff A.C., Kühnel G., Kemkes-Matthes B., Pralle H. Quantitative assessment of platelets, platelet microparticles, and platelet aggregates with flow cytometry. J. Lab. Clin. Med. 131:1998;507-517.
20. Wehmeier A., Südhoff T., Meierkord F. Relation of platelet abnormalities to thrombosis and hemorrhage in chronic myeloproliferative disorders. Semin. Thromb. Hemost. 23:1997;391-402.
21. Berckmans R.J., Nieuwland R., Böing A.N., Romijn F.P.H.T.M., Hack C.E., Sturk A. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb. Haemost. 85:2001;639-646.
22. Forlow S.B., McEver R.P., Nollert M.U. Leukocyte-leukocyte interactions mediated by platelet microparticles under flow. Blood. 95:2000;1317-1323.
23. Combes V., Joly P., Ambrosi P., Sabatier F., Camoin L., Pili J.et al. Platelet vesiculation in angina pectoris patients treated with coronary angioplasty. Thromb. Haemost. 83:2000;518.
24. Joop K., Berckmans R.J., Niewuland R., Berkhout J., Romijn F.P.H.T.M., Hack C.E., Sturk A. Microparticles from patients with multiple organ dysfunction syndrome and sepsis support coagulation through multiple mechanisms. Thromb. Haemost. 85:2001;810-820.
25. Hugel B., Socié G., Vu T., Toti F., Gluckman E., Freyssinet J.M.et al. Elevated levels of circulating procoagulant microparticles in patients with paroxysmal nocturnal hemoglobinuria and aplastic anemia. Blood. 93:1999;3451-3456.
26. de Bruijne-Admiraal L.G., Modderman P.W., von dem Borne A.E.G.Kr., Sonnenberg A. P-selectin mediates Ca2+-dependent adhesion of activated platelets to many different types of leukocytes: detection by flow cytometry. Blood. 80:1992;134-142.
27. Michelson A.D., Barnard M.R., Krueger L.A., Valeri C.R., Furman M.I. Circulating monocyte-platelet aggregates are a more sensitive marker of platelet activation than platelet surface p-selectin. Thromb. Haemost. 86:2001;OC2494. [Supplement].
28. Gemmell C.H., Ramirez S.M., Yeo E.L., Sefton M.V. Platelet activation in whole blood by artificial surfaces: identification of platelet-derived microparticles and activated platelet binding to leukocytes as material-induced activation events. J. Lab. Clin. Med. 125:1995;276-287.
29. Gawaz M., Fateh-Moghadam S., Pilz G., Gurland H.J., Werdan I. Platelet activation and interaction with leucocytes in patients with sepsis or multiple organ failure. Eur. J. Clin. Invest. 25:1995;843-851.
30. Ott I., Neumann F.J., Gawaz M., Schmitt M., Schömig A. Increased neutrophil-platelet adhesion in patients with unstable angina. Circulation. 94:1996;1239-1246.
31. Jones C.I., Payne D.A., Chapman P., Lamb D.J., Naylor A.R., Hayes P.D.et al. Simultaneous detection of tissue factor expression on platelet-leucocyte aggregates and free monocytes: increased levels in patients with atherosclerotic disease. Thromb. Haemost. 86:2001;P2716. [Supplement].
32. Rauch U., Bonderman D., Bohrmann B., Badimon J.J., Himber J., Riederer M.A.et al. Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor. Blood. 96:2000;170-175.
33. Veyradier A., Jenkins C.S.P., Fressinaud E., Meyer D. Acquired von Willebrand syndrome: from pathophysiology to management. Thromb. Haemost. 84:2000;175-182.
34. Dicato M.A., Schroell B., Berchem G.J., Duhem C., Ries F., Mahoh G.A. In essential thrombocythemia the mutations V Leiden, prothrombin and methylene-tetrahydrofolate reductase are not risk factor for thromboembolic disease. Blood. 94(Suppl. 1, Part 1):1999;488.
35. Jensen M.K., de Nully Brown P., Lund B.V., Nielsen O.J., Hasselbalch H.C. Increased circulating platelet-leukocyte aggregates in myeloproliferative disorders in correlated to previous thrombosis, platelet activation and platelet count. Eur. J. Haematol. 66:2001;143-151.
36. Manoharan A., Gemmell R., Brighton T., Dunkley S., Lopez K., Kyle P. Thrombosis and bleeding in myeloproliferative disorders: identification of at-risk patients with whole blood platelet aggregation studies. Br. J. Haematol. 105:1999;618-625.
37. Hoffman M., Monroe D.M. A cell-based model of hemostasis. Thromb. Haemost. 85:2001;958-965.